Publicacións en colaboración con investigadores/as de Hospital Clinico Universitario de Valencia (4)

2023

  1. Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers

    European Journal of Cancer, Vol. 185, pp. 105-118

2022

  1. Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG Study

    Clinical Genitourinary Cancer, Vol. 20, Núm. 1, pp. 25-34

2018

  1. Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma

    BMC Pharmacology and Toxicology, Vol. 19, Núm. 1

2013

  1. Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study

    British Journal of Cancer, Vol. 108, Núm. 12, pp. 2565-2572